nature.com·Apr 15, 2026
PerturbFate is a novel, high-throughput single-cell platform that utilizes CRISPR interference to identify key regulatory nodes and shared phenotypic responses associated with vemurafenib resistance in melanoma cells.
The introduction of PerturbFate as a high-throughput, single-cell platform provides a significant advancement in understanding CRISPR interference and its role in identifying regulatory nodes and phenotypic states. This could be crucial for developing targeted therapies for drug-resistant melanoma, highlighting a potential research direction or collaboration opportunity in the field of gene editing and cancer treatment.